Immunocore Holdings Hits Oversold Territory as RSI Dips Below 30

Immunocore Holdings PLC (IMCR) has seen its shares enter oversold territory, according to recent technical analysis. The stock hit a Relative Strength Index (RSI) reading of 29.5, suggesting that the recent downward price momentum may be reaching a point of exhaustion. The stock recently traded as low as $28.435 per share, closely approaching its 52-week low of $27.44. This technical weakness stands in stark contrast to the broader market, with the S&P 500 ETF (SPY) maintaining a significantly higher RSI of 68.0, indicating a divergence between the individual equity and the wider index. With a last trade of $28.56, IMCR is currently trading near the bottom of its annual range, which peaked at $40.7147. For bullish investors, an RSI reading below 30 often serves as a signal to look for entry points, anticipating a potential bounce back from these depressed levels. While the recent sell-off has been heavy, the current technical setup suggests the selling pressure may be winding down. Traders will likely monitor the $27.44 support level to determine if the stock stabilizes or continues its descent.